MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 189 filers reported holding MANNKIND CORP in Q2 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $35,000 | -73.3% | 54,414 | -74.3% | 0.00% | -100.0% |
| Q3 2016 | $131,000 | -55.1% | 211,752 | -15.9% | 0.00% | -50.0% |
| Q2 2016 | $292,000 | +5.8% | 251,680 | +46.6% | 0.00% | 0.0% |
| Q1 2016 | $276,000 | +12.7% | 171,683 | +1.8% | 0.00% | 0.0% |
| Q4 2015 | $245,000 | -54.7% | 168,689 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $541,000 | -43.6% | 168,689 | +0.0% | 0.00% | -42.9% |
| Q2 2015 | $960,000 | +5.3% | 168,652 | -3.8% | 0.01% | 0.0% |
| Q1 2015 | $912,000 | -0.4% | 175,353 | -0.2% | 0.01% | +16.7% |
| Q4 2014 | $916,000 | -11.8% | 175,695 | 0.0% | 0.01% | -14.3% |
| Q3 2014 | $1,038,000 | -46.2% | 175,695 | 0.0% | 0.01% | -46.2% |
| Q2 2014 | $1,931,000 | +304.8% | 175,695 | +48.0% | 0.01% | +333.3% |
| Q1 2014 | $477,000 | -23.9% | 118,726 | -1.3% | 0.00% | -25.0% |
| Q4 2013 | $627,000 | -7.2% | 120,326 | +1.4% | 0.00% | -20.0% |
| Q3 2013 | $676,000 | -10.2% | 118,648 | +2.4% | 0.01% | -16.7% |
| Q2 2013 | $753,000 | – | 115,921 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |